LINC01069

Across TCGA pan-cancer cohorts, LINC01069 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LINC01069 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LINC01069 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC01069 expression acts as an unfavorable survival marker, although some lineages such as STAD and LGG show a favorable association.

STAD, LGG, and BRCA are the cancer types where LINC01069 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	III,IV	0.720	0.312	.019	60	view →
LGG	DFS	Median	All	0.888	0.785	<.001	47	view →
BRCA	OS	Tertile	II,III,IV	0.806	0.916	.002	36	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
UVM	DFS	Tertile	All	0.790	0.527	.020	26	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
PCPG	OS	Tertile	All	0.773	1.000	.004	18	view →
PRAD	OS	Tertile	All	0.921	0.996	.011	12	view →
PAAD	DFS	Tertile	All	1.000	0.270	.032	9	view →
SKCM	OS	Tertile	IV	0.475	0.775	.006	9	view →
ACC	OS	Tertile	III,IV	0.189	0.764	.004	9	view →
LIHC	OS	Tertile	All	1.000	0.767	.033	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

LINC01069–STAD (DFS)

Open the STAD breakdown →